PE20030929A1 - 3- (IMIDAZOLIL) -2-ALCOXYPROPANOIC ACIDS - Google Patents
3- (IMIDAZOLIL) -2-ALCOXYPROPANOIC ACIDSInfo
- Publication number
- PE20030929A1 PE20030929A1 PE2003000058A PE2003000058A PE20030929A1 PE 20030929 A1 PE20030929 A1 PE 20030929A1 PE 2003000058 A PE2003000058 A PE 2003000058A PE 2003000058 A PE2003000058 A PE 2003000058A PE 20030929 A1 PE20030929 A1 PE 20030929A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- imidazol
- acid
- alcoxypropanoic
- imidazolil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A ACIDOS 3-(IMIDAZOLIL)-2-ALCOXIPROPANOICOS DE FORMULA I DONDE n ES 0-3; R1 ES ALQUILO C1-C6, ALQUENILO C2-C6, ALQUINILO C2-C6, ARILO, HETEROCICLO AROMATICO, ENTRE OTROS; R2, R3, R4, R6, R7 Y R9 SON H, ALQUILO C1-C6 DE CADENA LINEAL O RAMIFICADA CON OR10, HALO; R5 Y R8 SON H, ALQUILO C1-C6 DE CADENA LINEAL O RAMIFICADA; R10 ES H, ALQUILO C1-C6, ARILO. SON COMPUESTOS PREFERIDOS ACIDO (2S)-(-)-2-(2-AMINOETOXI)-3-(1-FENIL-1H-IMIDAZOL-4-IL)PROPANOICO, ACIDO (2S)-2-{((1R)-2-AMINO-1-METILETIL]OXI}-3-(1-(2-CICLOHEXILETIL)-1H-IMIDAZOL-4-IL)PROPANOICO, ACIDO (2S)-2-{((1R)-2-AMINO-1-METILETIL]OXI}-3-(1-FENIL-1H-IMIDAZOL-4-IL)PROPANOICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS MENCIONADOS SON UTILES EN EL TRATAMIENTO DE AFECCIONES TROMBOTICAS Y PATOLOGIAS ASOCIADAS CON LA DEPOSICION DE FIBRINAREFERS TO 3- (IMIDAZOLIL) -2-ALCOXYPROPANOIC ACIDS OF FORMULA I WHERE n IS 0-3; R1 IS C1-C6 ALKYL, C2-C6 ALKYL, C2-C6 ALKYL, ARYL, AROMATIC HETEROCYCLE, AMONG OTHERS; R2, R3, R4, R6, R7 AND R9 ARE H, C1-C6 ALKYL OF LINEAR OR BRANCHED CHAIN WITH OR10, HALO; R5 AND R8 ARE H, C1-C6 RENTAL OF LINEAR OR BRANCHED CHAIN; R10 IS H, C1-C6 ALKYL, ARYL. THE PREFERRED COMPOUNDS ARE ACID (2S) - (-) - 2- (2-AMINOETOXY) -3- (1-PHENYL-1H-IMIDAZOL-4-IL) PROPANOIC, ACID (2S) -2 - {((1R) - 2-AMINO-1-METHYLETHYL] OXY} -3- (1- (2-CYCLOHEXYLETHYL) -1H-IMIDAZOL-4-IL) PROPANOIC ACID (2S) -2 - {((1R) -2-AMINO-1 -METILETIL] OXI} -3- (1-PHENYL-1H-IMIDAZOL-4-IL) PROPANOICO, AMONG OTHERS, REFERS ALSO TO A PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR THE PREPARATION. THE MENTIONED COMPOUNDS ARE USEFUL IN THE TREATMENT OF AFFECTIONS THROMBOTIC AND PATHOLOGIES ASSOCIATED WITH FIBRIN DEPOSITION
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0201389A GB0201389D0 (en) | 2002-01-22 | 2002-01-22 | 3-(imidazolyl)-2-alkoxypropanoic acids |
| GB0202027A GB0202027D0 (en) | 2002-01-29 | 2002-01-29 | 3-(imidazolyl)-2-alkoxypropanoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030929A1 true PE20030929A1 (en) | 2003-11-05 |
Family
ID=27614792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000058A PE20030929A1 (en) | 2002-01-22 | 2003-01-17 | 3- (IMIDAZOLIL) -2-ALCOXYPROPANOIC ACIDS |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1467731A1 (en) |
| JP (1) | JP2005520811A (en) |
| KR (1) | KR20040077775A (en) |
| CN (1) | CN1620291A (en) |
| AP (1) | AP2004003084A0 (en) |
| AR (1) | AR038197A1 (en) |
| BR (1) | BR0307016A (en) |
| CA (1) | CA2472238A1 (en) |
| EA (1) | EA200400716A1 (en) |
| EC (1) | ECSP045200A (en) |
| HR (1) | HRP20040659A2 (en) |
| IL (1) | IL162677A0 (en) |
| IS (1) | IS7310A (en) |
| MA (1) | MA27167A1 (en) |
| MX (1) | MXPA04006573A (en) |
| NO (1) | NO20043457L (en) |
| OA (1) | OA12756A (en) |
| PA (1) | PA8563501A1 (en) |
| PE (1) | PE20030929A1 (en) |
| PL (1) | PL371487A1 (en) |
| TN (1) | TNSN04121A1 (en) |
| TW (1) | TW200302094A (en) |
| UY (1) | UY27615A1 (en) |
| WO (1) | WO2003061652A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005051384A1 (en) * | 2003-11-25 | 2005-06-09 | Pfizer Limited | Stabilised pharmaceutical compositions |
| CA2604912A1 (en) * | 2005-04-18 | 2006-10-26 | Bayer Schering Pharma Aktiengesellschaft | Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
| US20110213143A1 (en) | 2008-10-29 | 2011-09-01 | Taisho Pharmaceutical Co., Ltd. | Compound having tafia inhibitory activity |
| US8987242B2 (en) | 2008-12-05 | 2015-03-24 | Merck Sharp & Dohme Corp. | Morpholinone compounds as factor IXA inhibitors |
| US8642582B2 (en) | 2008-12-05 | 2014-02-04 | Merck Sharp & Dohme Corp. | Morpholinone compounds as factor IXa inhibitors |
| ES2608779T3 (en) * | 2010-03-18 | 2017-04-17 | Daiichi Sankyo Company, Limited | Cyclopropanecarboxylic acid derivative |
| DK2548871T3 (en) * | 2010-03-18 | 2017-11-06 | Daiichi Sankyo Co Ltd | CYCLOAL COOL SUBSTITUTED IMIDAZOLD DERIVATIVE |
| WO2014198620A1 (en) | 2013-06-10 | 2014-12-18 | Sanofi | Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals |
| EP3437641A4 (en) | 2016-03-29 | 2019-11-20 | Daiichi Sankyo Company, Limited | Inflammatory intestinal disease therapeutic agent |
| KR102616949B1 (en) | 2017-09-14 | 2023-12-22 | 다이이찌 산쿄 가부시키가이샤 | Compounds with a cyclic structure |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901572D0 (en) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| CN1443173A (en) * | 2000-08-17 | 2003-09-17 | 辉瑞大药厂 | Substituted imidazoles as TAFI a inhibitors |
-
2003
- 2003-01-10 BR BR0307016-6A patent/BR0307016A/en not_active IP Right Cessation
- 2003-01-10 EP EP03700059A patent/EP1467731A1/en not_active Withdrawn
- 2003-01-10 JP JP2003561596A patent/JP2005520811A/en active Pending
- 2003-01-10 EA EA200400716A patent/EA200400716A1/en unknown
- 2003-01-10 CN CNA03802599XA patent/CN1620291A/en active Pending
- 2003-01-10 CA CA002472238A patent/CA2472238A1/en not_active Abandoned
- 2003-01-10 OA OA1200400190A patent/OA12756A/en unknown
- 2003-01-10 WO PCT/IB2003/000060 patent/WO2003061652A1/en not_active Application Discontinuation
- 2003-01-10 KR KR10-2004-7011370A patent/KR20040077775A/en not_active Application Discontinuation
- 2003-01-10 AP APAP/P/2004/003084A patent/AP2004003084A0/en unknown
- 2003-01-10 PL PL03371487A patent/PL371487A1/en unknown
- 2003-01-10 IL IL16267703A patent/IL162677A0/en unknown
- 2003-01-10 MX MXPA04006573A patent/MXPA04006573A/en unknown
- 2003-01-16 TW TW092100889A patent/TW200302094A/en unknown
- 2003-01-17 PE PE2003000058A patent/PE20030929A1/en not_active Application Discontinuation
- 2003-01-20 UY UY27615A patent/UY27615A1/en not_active Application Discontinuation
- 2003-01-21 AR ARP030100165A patent/AR038197A1/en unknown
- 2003-01-22 PA PA20038563501A patent/PA8563501A1/en unknown
-
2004
- 2004-06-14 IS IS7310A patent/IS7310A/en unknown
- 2004-06-30 TN TNP2004000121A patent/TNSN04121A1/en unknown
- 2004-07-15 MA MA27786A patent/MA27167A1/en unknown
- 2004-07-19 HR HR20040659A patent/HRP20040659A2/en not_active Application Discontinuation
- 2004-07-22 EC EC2004005200A patent/ECSP045200A/en unknown
- 2004-08-19 NO NO20043457A patent/NO20043457L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY27615A1 (en) | 2003-08-29 |
| TW200302094A (en) | 2003-08-01 |
| PA8563501A1 (en) | 2004-08-31 |
| AR038197A1 (en) | 2005-01-05 |
| EP1467731A1 (en) | 2004-10-20 |
| IL162677A0 (en) | 2005-11-20 |
| WO2003061652A8 (en) | 2004-09-10 |
| CA2472238A1 (en) | 2003-07-31 |
| MA27167A1 (en) | 2005-01-03 |
| HRP20040659A2 (en) | 2004-10-31 |
| MXPA04006573A (en) | 2004-10-04 |
| KR20040077775A (en) | 2004-09-06 |
| WO2003061652A1 (en) | 2003-07-31 |
| CN1620291A (en) | 2005-05-25 |
| AP2004003084A0 (en) | 2004-09-30 |
| OA12756A (en) | 2006-07-03 |
| IS7310A (en) | 2004-06-14 |
| TNSN04121A1 (en) | 2006-06-01 |
| ECSP045200A (en) | 2004-08-27 |
| EA200400716A1 (en) | 2004-12-30 |
| PL371487A1 (en) | 2005-06-13 |
| JP2005520811A (en) | 2005-07-14 |
| NO20043457L (en) | 2004-08-19 |
| BR0307016A (en) | 2004-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20071132A1 (en) | MACROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA | |
| ECSP045317A (en) | PYRIDINOILPIPERIDINS AS AGONISTS OF 5-HT1F | |
| PE20021014A1 (en) | GLUTARAMIDE DERIVATIVES SUBSTITUTED WITH N-FENPROPYL CYCLOPENTILO AS NEP INHIBITORS FOR FSAD | |
| PE20020693A1 (en) | PEROXISOMAS PROLIFERATOR AGONISTS OF THE ACTIVATED ALPHA RECEPTOR | |
| PE20011314A1 (en) | DERIVATIVES OF N- (4-CARBAMIMIDOYL-PHENYL) -GLYCIN AS INHIBITORS OF THE FORMATION OF COAGULATION FACTORS Xa IXa AND THROMBIN | |
| PE20060777A1 (en) | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
| CY1105160T1 (en) | OXAZOLE DERIVATIVES WITH CARBOXYLIC ACID SUBSTITUENTS FOR USE AS PPAR-α AND -γ ACTIVATORS FOR THE TREATMENT OF DIABETES | |
| PE20060298A1 (en) | BENZHIMIDAZOLONE CARBOXYL ACID DERIVATIVES | |
| CO5720995A2 (en) | NEW COMPOUND | |
| NO20061432L (en) | N3 alkylated benzimidazole derivatives as MEK inhibitors | |
| DK0705254T3 (en) | Phenyl heterocyclic compounds as cyclooxygenase-2 inhibitors | |
| ES2189357T3 (en) | ISOCROMANO COMPOUNDS AND PROCEDURE FOR PRODUCTION. | |
| PE20030929A1 (en) | 3- (IMIDAZOLIL) -2-ALCOXYPROPANOIC ACIDS | |
| PE20021088A1 (en) | AMIDES OF ANTRANILIC ACIDS, PROCEDURE FOR THEIR PREPARATION AS WELL AS PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM | |
| PE20040666A1 (en) | NOVEL PIPERIDINE DERIVATIVES | |
| NO20051011L (en) | Chiral oxazole-arylpropionic acid derivatives and their use as PPAR agonists | |
| PE20050012A1 (en) | BENZOPYRANE COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITORS | |
| PE20040907A1 (en) | ANILINOPYRAZOLE DERIVATIVES | |
| CY1109085T1 (en) | NEW SALTS | |
| PE20020064A1 (en) | NITRILE BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF CISTEIN PROTEASES | |
| PE20030763A1 (en) | HIV INTEGRASE INHIBITORS | |
| EA200300927A1 (en) | A NEW METHOD OF INDUSTRIAL SYNTHESIS OF TETROSETTED ETHERS 5- [BIS (PHYCH) AND-3-TIOPHENCARBONIC ACID AND APPLICATION FOR THE SYNTHESIS OF BATHELETHYLETHYLETCHENKARBONOVOI ACID AND APPLICATION FOR SYNTHESIS | |
| PE20080342A1 (en) | 2- (AMINO-SUBSTITUTED) -BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS | |
| PE20021058A1 (en) | INDOLINONES SUBSTITUTE IN POSITION 6, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| MXPA04005940A (en) | 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |